We are monitoring the impact of COVID-19 on North America Cardiac Marker Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4804
Share on
Share on

North America Cardiac Marker Testing Market Research Report – Segmented By Type, Product, Disease, Testing & Country (The United States, Canada & Rest of North America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4804
Pages: 145

North America Cardiac Marker Testing Market Size (2021 to 2026):

The size of the North America Cardiac Marker Testing Market is anticipated to grow at 7.89% CAGR from 2021 to 2026. The market is expected to be valued at USD 1.12 billion in 2021 and is projected to reach USD 1.64 billion by 2026.

Growing funds and investments by different organizations to surge the research and clinical trials rise in the aging population. In 2016, the number of older people aged 65 years and above was nearly 8.5%. By the end of 2050, the count is expected to surge over 17%, according to the National Institutes of Health (NIH). The rise in the aging population is associated with increased cardiovascular diseases like cardiac failure, myocardial infarction, and angina pectoris. The rising popularity of point of care testing and the rapid development of healthcare infrastructure accelerates the growth. Also, the government and research institutes' determined efforts to deal with severe cardiac diseases and growing research and development activities relevant to the market are to boost the market in the region.

Less availability of test kits and high competition among the key players in the market, the entrance for new players in the market cannot mark prints effectively are hindering the market growth in the region. The expensive nature of the tests associated with some tests' less specificity is acting as a barrier to market growth in the area.

This research report on the North America Cardiac Marker Testing Market has been segmented and sub-segmented into the following categories:

  • By Type: Troponin I & T, CK-MB, Myoglobin, BNP and HsCRP
  • By Product: Reagent, Instrument (Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA)
  • By Disease: Acute Coronary Syndrome, Myocardial Infarction and Congestive Heart Failure
  • By Testing Lab and POC
  • By Country: The United States, Canada & Rest of North America

Regional Analysis:

North America held the largest share of the global cardiac marker testing market. Factors such as public-private initiatives to increase awareness related to early cardiac disease diagnosis in patients and physicians and increasing knowledge about technological advancements among lab professionals and cardiologists due to ongoing conferences and seminars are the key factors aiding the growth of the markets.

The United States is ruling the market in this region based on the increasing obese population, which has become a health challenge in the last few years. Every sixth person is obese, and the number of obese people in the region has been doubled, according to WHO. 1.9 billion Adults are suffering from obesity, and over 650 were obese. Obesity is concerned with the growing number of cardiovascular diseases like congestive heart failure and more. Surging government observation in minimizing the length of the stay of the patient and different modes of patient care like an emergency room, homecare and near-patient testing and advancements in healthcare for personalized medicine has surged the significance of cardiac makers for fast, efficient, and quality maintenance of the health stimulating the market growth in the region.

Promising Companies leading the North America Cardiac Marker Testing Market Profiled in the report are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS Roche Diagnostics Ltd., Abbott Laboratories, Siemens AG, Danaher Corporation, Alere Inc., bioMérieux SA, LSI Medience Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd, and Guangzhou Wondfo Biotech Co. Ltd.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 Product        

                                5.1.1 Introduction                                                           

                                5.1.2 Reagents and Kits                                                

                                5.1.3 Instruments                                                           

                                                5.1.3.1 Chemiluminescence                                        

                                                5.1.3.2 Immunofluorescence                                     

                                                5.1.3.3 Elisa                                        

                                                5.1.3.4 Immunochromatography                                              

                                5.1.4  Y-o-Y Growth Analysis, By Product                                                              

                                5.1.5  Market Attractiveness Analysis, By Product                                                            

                                5.1.6  Market Share Analysis, By Product                                                              

                5.2 Type              

                                5.2.1 Introduction                                                           

                                5.2.2 Troponin I & T                                                        

                                5.2.3 CK-MB                                                      

                                5.2.4 Myoglobin                                                               

                                5.2.5 BNP                                                            

                                5.2.6 hsCRP                                                        

                                5.2.7 Y-o-Y Growth Analysis, By Type                                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                                   

                                5.2.9 Market Share Analysis, By Type                                                     

                5.3 Disease        

                                5.3.1 Introduction                                                           

                                5.3.2 Acute Coronary Syndrome                                                               

                                5.3.3 Myocardial Infarction                                                         

                                5.3.4 Congestive Heart Failure                                                   

                                5.3.5 Y-o-Y Growth Analysis, By Disease                                                                

                                5.3.6  Market Attractiveness Analysis, By Disease                                                             

                                5.3.7  Market Share Analysis, By Disease                                                              

                5.4 Type of Testing         

                                5.4.1 Introduction                                                           

                                5.4.2 Lab                                                             

                                5.4.3 Point-Of-Care Testing                                                        

                                5.4.4 Y-o-Y Growth Analysis, By Type of Testing                                                                

                                5.4.5  Market Attractiveness Analysis, By Type of Testing                                                             

                                5.4.6  Market Share Analysis, By Type of Testing                                                               

6. Geographical Analysis                              

                6.1 Introduction               

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Product                                           

                                                6.1.3.3 By Type                                 

                                                6.1.3.4 By Disease                                           

                                                6.1.3.5 By Type of Testing                                            

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Product                                           

                                                6.1.4.3 By Type                                 

                                                6.1.4.4 By Disease                                           

                                                6.1.4.5 By Type of Testing                                            

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Product                                           

                                                6.1.5.3 By Type                                 

                                                6.1.5.4 By Disease                                           

                                                6.1.5.5 By Type of Testing                                            

                6.2 United States            

                6.3 Canada         

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8.Market Leaders' Analysis                         

                8.1 Getinge Group          

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Medtronic plc            

                8.3 LivaNova PLC             

                8.4 XENIOS Roche Diagnostics Ltd.           

                8.5 Abbott Laboratories                                                               

                8.6 Siemens AG                                                               

                8.7 Danaher Corporation             

                8.8 Alere Inc.     

                8.9 BioMérieux SA          

                8.10 LSI Medience Corporation 

9.Competitive Landscape                     

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, Collaborations, and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                    

                a) List of Tables                

                b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of Type, Product, Disease, and Testing along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North America Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Cardiac Marker Testing  Market By Type, From 2021 to 2026( USD Billion )
  2. North America Troponin I & T Market By Region, From 2021 to 2026( USD Billion )
  3. North America Insulin Delivery Market By Region, From 2021 to 2026( USD Billion )
  4. North America CK-MB Market By Region, From 2021 to 2026( USD Billion )
  5. North America Myoglobin Market By Region, From 2021 to 2026( USD Billion )
  6. North America BNP Market By Region, From 2021 to 2026( USD Billion )
  7. North America hsCRP Market By Region, From 2021 to 2026( USD Billion )
  8. North America Cardiac Marker Testing  Market By Product, From 2021 to 2026( USD Billion )
  9. North America Reagent Market By Region, From 2021 to 2026( USD Billion )
  10. North America Instrument Market By Region, From 2021 to 2026( USD Billion )
  11. North America Chemiluminescence Market By Region, From 2021 to 2026( USD Billion )
  12. North America Immunofluorescence Market By Region, From 2021 to 2026( USD Billion )
  13. North America Immunochromatography Market By Region, From 2021 to 2026( USD Billion )
  14. North America ELISA Market By Region, From 2021 to 2026( USD Billion )
  15. North America Cardiac Marker Testing  Market By Disease, From 2021 to 2026( USD Billion )
  16. North America Acute Coronary Syndrome Market By Region, From 2021 to 2026( USD Billion )
  17. North America Myocardial Infarction Market By Region, From 2021 to 2026( USD Billion )
  18. North America Congestive Heart Failure Market By Region, From 2021 to 2026( USD Billion )
  19. North America Cardiac Marker Testing  Market By Testing, From 2021 to 2026( USD Billion )
  20. North America Lab Market By Region, From 2021 to 2026( USD Billion )
  21. North America POC  Market By Region, From 2021 to 2026( USD Billion )
  22. United States Cardiac Marker Testing  Market By Type, From 2021 to 2026( USD Billion )
  23. United States Cardiac Marker Testing  Market By Product, From 2021 to 2026( USD Billion )
  24. United States Cardiac Marker Testing  Market By Disease, From 2021 to 2026( USD Billion )
  25. United States Cardiac Marker Testing  Market By Testing, From 2021 to 2026( USD Billion )
  26. Canada Cardiac Marker Testing  Market By Type, From 2021 to 2026( USD Billion )
  27. Canada Cardiac Marker Testing  Market By Product, From 2021 to 2026( USD Billion )
  28. Canada Cardiac Marker Testing  Market By Disease, From 2021 to 2026( USD Billion )
  29. Canada Cardiac Marker Testing  Market By Testing, From 2021 to 2026( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample